Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Dr. Stephen Schroeder,
This was a session on a clinically relevant and also controversial topic with excellent presentations and a vivid discussion.
Calcium scoring Prof. Knuuti gave a review of the currently available data, as well as on the current recommendations and guidelines. Especially, in intermediate risk patients, a coronary calcium scan might be considered to furthermore estimate an individual’s risk. But only, if diagnostics is potentially followed by a therapy.
Nuclear imaging Prof. Zellweger gave an overview on nuclear imaging. He highlighted the difference of morphologic and functional imaging. Which must be considered not oppositional, but additive. Nuclear imaging might be useful in asymptomatic high risk patients, e.g. diabetics.
Computed tomography angiography Dr.Scholte started his presentation with the statement “There is non indication for CTA in asymptomatic patients”. According to the current recommendations, a CTA might be considered in symptomatic patients with intermediate pre-test probability of having a significant lesion. However, Dr. Scholte showed some clinical cases, e.g. after radiation because of M.Hodgkin, underlining that a CTA might be also useful in very selected cases.
Cardiac magnetic resonance Prof.Schwitter gave an overview of the potential of CMTR in asymptomatic patients, focusing not only on CAD, but also on HCM or ARVD. He showed a review of the relevant literature, especially also on the prognostic value of CMR to predict the probability of developing an acute myocardial infarction in the future. In the absence of any ischemia, the prognosis is excellent.
Concluding, this was, all in all, an excellent session, not resolving all the open issues in this context, but giving a very good overview on the potential of the different techniques. The most important point, apart from the accurate patient selection, remains of course the appropriate expertise when using these modalities.
Risk assessment in the asymptomatic patient
© 2017 European Society of Cardiology. All rights reserved